On-Demand Webinars
Cell and Gene Therapies: Lessons learned and pathways to successful commercialization
On-Demand Webinar
Jul 4, 2022
Biotech by the Lake Investor Summit: “Hot Topics in Protein Therapeutics and Technologies”
On-Demand Webinar
Jun 28, 2022
Guidemark Health is Now Lumanity: The Specialty Agency Enters a New Phase
On-Demand Webinar
Jun 27, 2022
Navigating the Latest Market Downturn Amidst an Unprecedented Biotech Glut
On-Demand Webinar
Jun 23, 2022
State of the Art in Immuno-Oncology: Beyond PDx Inhibitors – or Not So Much
On-Demand Webinar
May 22, 2022
Cancer Progress 2022 – Event Highlights and Session Recordings
On-Demand Webinar
May 12, 2022
Building on Success – Clinical and Commercial Dynamics in Heme Malignancies and Hematopoietic Transplantation
On-Demand Webinar
May 12, 2022
Selling the Cell – Cost-benefit Considerations for Complex Therapeutics
On-Demand Webinar
May 12, 2022
Does RNA Rule the World?
On-Demand Webinar
May 11, 2022
Key Multi-Stakeholder Considerations In Early Stage Commercial Deal-Making
On-Demand Webinar
May 10, 2022
A Platform For Success – Strategic Imperatives In Building And Growing Discovery Platforms
On-Demand Webinar
May 10, 2022
The Venture Investor Outlook & Mindset
On-Demand Webinar
Apr 21, 2022
Precision oncology 2.0: What can it deliver?
On-Demand Webinar
Mar 3, 2022
Changes to the National Institute for Health and Care Excellence (NICE) Methods; Implications for the UK, US and Global Evidence Development
Following the release of NICE’s updated manual on Monday, January 31, 2022, we hosted a free webinar on Wednesday, February 23, 2022, where we presented our review of the key changes to the manual. We were also joined by R. Brett McQueen, ICER reviewer and Assistant Professor of the Department of Clinical Pharmacy for the University of Colorado, for a discussion of these key changes and their potential implications.
On-Demand Webinar
Feb 23, 2022